SCHEMBL1737992

SCHEMBL1737992

COc1cccc(Cn2c(C)c(C)c3cc(C(=O)O)nc(N4CCc5ccccc5C4)c32)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 2/20 0.43
MAPT P10636 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
MAOB P27338 2/20 0.40
HTR6 P50406 2/20 0.40
PTGER4 P35408 2/20 0.40
PTGER2 P43116 2/20 0.40
ALDH1A1 P00352 3/20 0.39
GAA P10253 1/20 0.39
PKM P14618 1/20 0.39
CCR2 P41597 1/20 0.39
PRMT5 O14744 1/20 0.39
WDR77 Q9BQA1 1/20 0.39
TSHR P16473 2/20 0.38
HPGD P15428 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
PPARG P37231 1/20 0.38
MAPK1 P28482 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1737799 0.93 MAPT (0.40) FABP4MAPTL3MBTL1MAOBHTR6
SCHEMBL1735831 0.91 FABP4 (0.45) FABP4MAPTALDH1A1GAAPKM
SCHEMBL1735607 0.90 PRMT5 (0.42) FABP4MAPTALDH1A1GAAPRMT5
SCHEMBL1737494 0.90 ALDH1A1 (0.41) FABP4MAPTALDH1A1TSHRHPGD
Hydrochloric Acid SCHEMBL1739172 0.89 ALDH1A1 (0.40) FABP4MAPTALDH1A1TSHRHPGD
SCHEMBL1737993 0.89 MAPT (0.41) FABP4MAPTL3MBTL1MAOBHTR6
SCHEMBL1737743 0.89 MAOB (0.39) FABP4MAPTL3MBTL1MAOBHTR6
SCHEMBL1739793 0.89 LMNA (0.45) MAPTL3MBTL1ALDH1A1TSHRHPGD
SCHEMBL1737472 0.89 TMEM97 (0.42) FABP4MAPTHTR6ALDH1A1TSHR
SCHEMBL1735623 0.88 FABP3 (0.41) FABP4PTGER4PTGER2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1784404-B1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORP (KR) 2011-11-16 EP claimed
US-20110263306-A1 COMPUTER SYSTEM AND PROGRAM NAMCO BANDAI GAMES INC. (JP) 2011-10-27 US claimed
US-7662832-B2 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2010-02-16 US claimed
US-20070219230-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2007-09-20 US claimed
US-8188114-B2 Pyrrolo[2,3-C]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2012-05-29 US disclosed
EP-1784404-B1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORP (KR) 2011-11-16 EP disclosed
US-20110263306-A1 COMPUTER SYSTEM AND PROGRAM NAMCO BANDAI GAMES INC. (JP) 2011-10-27 US disclosed
US-20100069430-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2010-03-18 US disclosed
US-7662832-B2 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2010-02-16 US disclosed
US-20070219230-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069430-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF PGA5, ATP6AP1, ATP6V1H FABP4 4680/4885MAPT 3920/4885L3MBTL1 4876/4885
US-20070219230-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF PGA5, ATP6AP1, ATP6V1H FABP4 4680/4885MAPT 3920/4885L3MBTL1 4876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.